+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fluzone"

Swine Flu Vaccination Market Report 2025 - Product Thumbnail Image

Swine Flu Vaccination Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Quadrivalent Market Report 2025 - Product Thumbnail Image

Quadrivalent Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
FLUZONE QUADRIVALENT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FLUZONE QUADRIVALENT Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
FLUBLOK QUADRIVALENT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FLUBLOK QUADRIVALENT Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
From
From
  • 12 Results (Page 1 of 1)
Loading Indicator

Fluzone is a brand of influenza vaccine manufactured by Sanofi Pasteur, a global biopharmaceutical company. The vaccine is approved for use in individuals aged 6 months and older, and is available in both injectable and intranasal forms. It is designed to protect against the four most common strains of influenza virus. The vaccine is typically administered annually, usually in the fall, to provide protection against the flu season. Fluzone is one of many influenza vaccines available on the market. Other brands include Afluria, Fluarix, Flucelvax, and Flublok. These vaccines are typically administered by healthcare providers in a doctor's office or clinic. In addition, some pharmacies and retail stores offer flu shots. The market for influenza vaccines is highly competitive, with many companies offering similar products. Some of the major players in the market include Sanofi Pasteur, GlaxoSmithKline, Merck, Pfizer, and Novartis. Show Less Read more